Williams Paul Anthony
SEC CIK 1961994 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| EBS | Emergent BioSolutions Inc. | SVP, Products Business | 159.1K | — | $59.0K | 21 | 2023-02-23 | 2026-07-01 |
Most active insiders at EBS, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | DeGolyer Donald W | Dir | — | $317.6K |
| 2 | Glessner Coleen | EVP, Quality, Ethics, CPL | — | $306.1K |
| 3 | Richard Ronald | Dir | — | $263.1K |
| 4 | Dayal Sujata Tyagi | Dir | — | $201.1K |
| 5 | Zoon Kathryn C | Dir | — | $144.5K |
| 6 | Katkin Keith | Dir | — | $128.2K |
| 7 | Williams Paul Anthony | SVP, Products Business | — | $59.0K |
| 8 | Lowry Simon C | SVP, CMO, R, D | — | — |
| 9 | Perl Jessica | SVP, GC, Corp Sec | — | — |
| 10 | Hartzel William | SVP, Bioservices | — | — |
Transactions 21
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| T | 2026-07-02 12:57 | 2026-07-01 | EBS | Emergent BioSolutions Inc. | Williams Paul Anthony | SVP, Products Business | S - Sale | $8.40 | -3,000 | 159.1K | -2% | -$25.2K |
| 2026-06-10 15:09 | 2026-06-08 | EBS | Emergent BioSolutions Inc. | Williams Paul Anthony | SVP, Products Business | F - Tax | $8.00 | -694 | 162.1K | -0.4% | -$5,552 | |
| 2026-05-01 16:30 | 2026-04-29 | EBS | Emergent BioSolutions Inc. | Williams Paul Anthony | SVP, Products Business | A - Grant | $0.00 | +100.1K | 162.8K | +160% | $0 | |
| T | 2026-04-03 16:05 | 2026-04-01 | EBS | Emergent BioSolutions Inc. | Williams Paul Anthony | SVP, Products Business | S - Sale | $8.44 | -4,000 | 62.7K | -6% | -$33.8K |
| D | 2026-03-05 | 2026-03-05 | EBS | Emergent BioSolutions Inc. | Williams Paul Anthony | SVP, Products Business | F - Tax | $8.44 | -9,397 | 66.7K | -12% | -$79.3K |
| 2026-03-03 | 2026-03-01 | EBS | Emergent BioSolutions Inc. | Williams Paul Anthony | SVP, Products Business | F - Tax | $8.15 | -116 | 76.1K | -0.2% | -$945.40 | |
| 2026-02-10 | 2026-02-06 | EBS | Emergent BioSolutions Inc. | Williams Paul Anthony | SVP, Products Business | D - Sale to Iss | $10.92 | -8,655 | 77.2K | -10% | -$94.5K | |
| 2026-02-10 | 2026-02-06 | EBS | Emergent BioSolutions Inc. | Williams Paul Anthony | SVP, Products Business | F - Tax | $10.92 | -1,022 | 76.2K | -1% | -$11.2K | |
| 2025-06-10 | 2025-06-08 | EBS | Emergent BioSolutions Inc. | Williams Paul Anthony | SVP, Products Business | F - Tax | $6.63 | -464 | 85.9K | -0.5% | -$3,076 | |
| D | 2025-03-10 | 2025-03-06 | EBS | Emergent BioSolutions Inc. | Williams Paul Anthony | SVP, Products Business | A - Grant | $0.00 | +62.5K | 86.3K | +262% | $0 |
| M | 2025-03-04 | 2025-02-28+ | EBS | Emergent BioSolutions Inc. | Williams Paul Anthony | SVP, Products Business | F - Tax | $7.48 | -498 | 24.0K | -2% | -$3,725 |
| 2024-07-10 | 2024-07-08 | EBS | Emergent BioSolutions Inc. | Williams Paul Anthony | SVP, Products Business | F - Tax | $8.13 | -85 | 24.3K | -0.3% | -$691.05 | |
| 2024-06-11 | 2024-06-08 | EBS | Emergent BioSolutions Inc. | Williams Paul Anthony | SVP, Products Business | F - Tax | $6.19 | -464 | 24.4K | -2% | -$2,872 | |
| M | 2024-03-04 | 2024-02-29+ | EBS | Emergent BioSolutions Inc. | Williams Paul Anthony | SVP, Products Business | F - Tax | $3.27 | -587 | 25.0K | -2% | -$1,918 |
| 2024-02-27 | 2024-02-23 | EBS | Emergent BioSolutions Inc. | Williams Paul Anthony | SVP, Products Business | F - Tax | $2.74 | -105 | 25.5K | -0.4% | -$287.70 | |
| 2023-11-14 | 2023-11-13 | EBS | Emergent BioSolutions Inc. | Williams Paul Anthony | SVP, Products Business | F - Tax | $1.82 | -566 | 25.6K | -2% | -$1,030 | |
| 2023-07-24 | 2023-07-08 | EBS | Emergent BioSolutions Inc. | Williams Paul Anthony | SVP, Products Business | F - Tax | $0.00 | -85 | 26.1K | -0.3% | $0 | |
| DM | 2023-06-13 | 2023-06-09 | EBS | Emergent BioSolutions Inc. | Williams Paul Anthony | SVP, Products Business | A - Grant | $0.00 | +13.8K | 26.2K | +112% | $0 |
| DM | 2023-03-06 | 2023-03-02 | EBS | Emergent BioSolutions Inc. | Williams Paul Anthony | SVP, Products Business | A - Grant | $0.00 | +3,462 | 12.4K | +39% | $0 |
| 2023-03-02 | 2023-02-28 | EBS | Emergent BioSolutions Inc. | Williams Paul Anthony | SVP, Products Business | F - Tax | $12.38 | -371 | 8,916 | -4% | -$4,593 | |
| 2023-02-27 | 2023-02-23 | EBS | Emergent BioSolutions Inc. | Williams Paul Anthony | SVP, Products Business | F - Tax | $14.30 | -89 | 9,287 | -0.9% | -$1,273 |
Purchase Sale Sale after option exercise All abbreviations